Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (5463)	5/11/2009 2:45:14 PM
From: peter michaelson	Read Replies (1) \| Respond to of 6370

Did you know you are posting on the hottest thread on SI? siliconinvestor.com Maybe they need to adjust the algorithm.

To: RockyBalboa who wrote (5463)	5/18/2009 11:24:34 AM
From: Kevin Podsiadlik	Read Replies (1) \| Respond to of 6370

I have no idea about the FDA's susceptibility to bribery, but maybe if HEB markets Ampligen as an treatment for market insanity, they'd have something. Seriously, what kind of stock decisively busts its secondary on the third day, then doubles off the lows on the sixth on explicit "no news"? Only thing I can figure is HEB is investing some of its newly won funding into more stock promotion, but to what end now? (Edit: I thought maybe it was the $1.65 warrants but those don't unlock until November. Curiouser still...)